000590 啟迪藥業
按盤價 
7.760 -0.740 (-8.706%)
7.760 -0.740 (-8.706%) | 2024/09 - 九個月 | 2023/12 | 2022/12 | 2021/12 | 2020/12 | 盈利能力分析 |
| 淨資產收益率 ROE (%) | -4.011 | 3.550 | 2.627 | 5.348 | 3.587 |
| 總資產報酬率 ROA (%) | -2.520 | 2.178 | 1.697 | 3.811 | 2.613 |
| 投入資產回報率 ROIC (%) | -3.006 | 2.644 | 2.064 | 4.642 | 3.289 | 邊際利潤分析 |
| 銷售毛利率 (%) | 46.209 | 52.421 | 51.123 | 55.277 | 55.720 |
| 營業利潤率 (%) | -11.549 | 4.982 | 6.468 | 14.081 | 10.100 |
| 息稅前利潤/營業總收入 (%) | -11.060 | 7.855 | 5.213 | 11.822 | 7.540 |
| 淨利潤/營業總收入 (%) | -13.057 | 6.151 | 5.174 | 11.782 | 8.260 | 收益指標分析 |
| 經營活動淨收益/利潤總額(%) | 112.394 | 39.883 | 71.632 | 75.465 | 90.630 |
| 價值變動淨收益/利潤總額(%) | -0.279 | 9.387 | 12.668 | 7.954 | 1.375 |
| 營業外收支淨額/利潤總額(%) | 2.964 | 32.075 | -3.643 | -1.237 | -0.517 | 償債能力分析 |
| 流動比率 (X) | 2.223 | 2.169 | 1.949 | 2.962 | 3.159 |
| 速動比率 (X) | 1.549 | 1.646 | 1.514 | 2.499 | 2.843 |
| 資產負債率 (%) | 36.765 | 36.740 | 39.804 | 29.500 | 0.277 |
| 帶息債務/全部投入資本 (%) | 15.586 | 14.258 | 16.113 | 2.535 | -0.473 |
| 股東權益/帶息債務 (%) | 474.836 | 532.133 | 453.648 | 3,359.071 | -18,717.728 |
| 股東權益/負債合計 (%) | 170.755 | 171.125 | 150.362 | 238.288 | 260.797 |
| 利息保障倍數 (X) | -13.138 | 15.094 | -5.070 | -5.662 | -3.006 | 營運能力分析 |
| 應收賬款周轉天數 (天) | 19.530 | 20.426 | 12.631 | 1.301 | 5.168 |
| 存貨周轉天數 (天) | 321.494 | 232.150 | 215.184 | 183.880 | 150.289 |
| 備註： | 報價延遲最少15分鐘，資料更新時間為 29/11/2024 16:30 |
- 經濟通
- 強化版MQ
- 強化版TQ
- 財曆
- Mobile
Web
